Related Experiment Videos
Tumor resistance to antimetabolites
1Department of Surgery, University of Liverpool, UK.
Abstract:
1. The inherent or acquired resistance of certain tumors to cytotoxic drug therapy is a major clinical problem. 2. Resistance to the chemotherapeutic antimetabolites (e.g., methotrexate, 5-fluorouracil, tomudex and gemcitabine) is no exception. 3. Mechanisms of resistance include mutations, amplification of target genes, altered drug transport, differences in nucleoside and nucleobase salvage pathways, DNA damage-response pathways and cell cycle control pathways.
Insights
Tumor resistance to chemotherapy is a significant clinical challenge. Mechanisms include genetic mutations, altered drug transport, and changes in cellular pathways affecting drug response.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Tumor resistance to cytotoxic drugs presents a major clinical obstacle.
- Antimetabolite chemotherapeutics, including methotrexate and gemcitabine, are frequently affected by resistance.
- Understanding resistance mechanisms is crucial for improving cancer treatment efficacy.
Purpose of the Study:
- To elucidate the multifaceted mechanisms underlying tumor resistance to antimetabolite chemotherapy.
- To identify key molecular and cellular pathways involved in drug resistance.
- To provide a foundation for developing strategies to overcome therapeutic resistance.
Main Methods:
- Review and synthesis of existing literature on drug resistance in oncology.
- Analysis of reported genetic alterations and pathway dysregulations.
- Categorization of resistance mechanisms based on molecular and cellular processes.
Main Results:
- Tumor resistance can be inherent or acquired during treatment.
- Key resistance mechanisms involve target gene mutations or amplification, altered drug transport, and modified salvage pathways.
- Dysregulation of DNA damage response and cell cycle control pathways also contributes significantly to resistance.
Conclusions:
- Tumor resistance to antimetabolites is complex, involving multiple interconnected mechanisms.
- Targeting these diverse resistance pathways may enhance the effectiveness of chemotherapy.
- Further research into specific resistance mechanisms can guide the development of novel therapeutic strategies.